Kaplan-Meier curves revealed that lung cancer patients with higher IGF2BP3 expression levels were associated with poor overall survival (Fig. S8H), suggesting that increased IGF2BP3 levels contribute to lung cancer progression. This evidence concerns the gene IGF2BP3 and lung cancer.